|
|
The FDA recognizes 118 routes of administration.
The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.
This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.
More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.
Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.